David is originally from Michoacan, but completed his secondary education in California before moving to New York to study his first degree in Biochemistry. David recently completed his PhD in Medicine at the University of Cambridge with Prof. Menna Clatworthy. David is interested in meningeal neuroimmune interactions during infection and neurodegeneration. He is currently a postdoctoral research associate at the University of Manchester in the lab of Prof Matt Hepworth.

Carlos is a Principal Investigator at the Champalimaud Centre for the Unknown in Portugal. After completing his undergraduate studies in Puebla, Mexico, he undertook a PhD at the Universidad Complutense de Madrid under the supervision of Cristina Casals. Carlos then completed his postdoctoral training with Judi Allen FRS and Dietmar Zaiss at the University of Edinburgh, and later with Caetano Reis e Sousa FRS at the Francis Crick Institute in London. His lab investigates the immune regulation of the development and function of myeloid cells.

Marion E. G. Brunck obtained her PhD in Immunology and Systems Biology from the University of Queensland (Australia) in 2015 and completed her postdoctoral training at the Translational Research Institute in Brisbane in 2016. She is a researcher at the Instituto de Investigaciones Biomédicas (UNAM, Mexico City). Her lab explores maternal determinants of the immune system of human milk, and how it shapes neonatal gut development and contributes to both immediate and long-term infant health. 

Carla Nowosad received undergraduate degrees from the University of Warwick and a Ph.D. from the Francis Crick Institute, National Institute for Medical Research Mill Hill. After completing her postdoctoral fellowship at Rockefeller University, she started her laboratory in the department of Pathology and the Translational Immunology Center at New York University Grossman School of Medicine in late 2021. Her research focuses on how B cells make decisions in the complex microenvironment of the intestine.

Dr Robles-Espinoza received a BSc in genome sciences from UNAM and a PhD in cancer genetics from the University of Cambridge in 2015. After a short postdoc at the Wellcome Sanger Institute, she returned to her home country to start her research group at the International Laboratory for Human Genome Research (LIIGH), part of UNAM, in its Juriquilla campus. During her postdoctoral studies, she worked with a team to study more than 400 exomes from melanoma patients, where they could estimate that patients carrying at least one variant allele of the MC1R gene (which participates in melanin production and of which red-haired individuals normally carry two variant copies) have more sun-associated mutations in their tumours comparable to two extra decades of life. At LIIGH-UNAM, her research group works to understand the genomic variants, driver genes, and environmental conditions that lead to cancer in Latin American populations.

Paula Licona-Limon received her PhD in Biomedical Sciences from the Universidad Nacional Autónoma de México (UNAM). Her postdoctoral studies were under the supervision of Dr Richard Flavell at Yale University. Paula currently works at the Department of Cellular and Developmental Biology as an Associate Professor in the Institute of Cellular Physiology at UNAM. She does research in molecular and cellular immunology related to cancer, autoimmunity and infection. She studies basic aspects of the immune response using transgenic/reporter/deficient murine models for different cytokines and signaling molecules. Her lab also works on clinical Immunology focused on immunotherapy designs.